Vermont Bill Would Decriminalize Psychedelics In Interest of Public Health
Vermont is looking to decriminalize psychedelics as part of its efforts to improve public health in the state.
Author: Jennifer Walker-Journey
Algernon to Investigate DMT Microdose for Stroke Treatment
Algernon Pharmaceuticals is exploring the little-researched psychedelic substance DMT to see if it has potential in treating stroke patients.
Ketamine Therapy May Help Slow Progression of ALS
New research is looking at ketamine therapy as a potential aid in slowing the deadly disease ALS, amyotrophic lateral sclerosis.
Core One Labs and Ketamine Infusion Centers to Explore DMT Therapy for Anxiety and Depression
Core One Labs is exploring DMT therapy for anxiety and depression in a partnership with Ketamine Infusion Centers.
Beckley Psytech Explores Psilocybin for Headache Treatment
A new study is looking at how psilocybin treatment may help to reduce debilitating short-lasting unilateral neuralgiform headache attacks.
Canada’s First End of Life Psilocybin Treatment Brought Peace to Terminal Man
Tony White may have lost his battle with cancer, but becoming the first end of life recipient of psilocybin treatment has changed everything.
Are ‘Magic’ Psilocybin Truffles the Fountain of Youth? New Study Looks at Anti-Aging Benefits
New research is looking at psilocybin truffles as a potential anti-aging tool and aid in treating age-related psychiatric disorders.
Can An App Give You a Psychedelic Experience Without Taking Drugs? Lumenate Says Yes
Lumenate is an app that simulates a psychedelic experience without the need for illegal substances.
Minority Veterans Organization Urges Congress to Loosen Restrictions on Psychedelic Therapies
A minority veterans organization wants access to psychedelic therapies for PTSD and depression. It’s urging Congress to take action.
Missouri Bill Would Give Terminally Ill Patients Access to Psychedelic Therapies
Missouri residents with terminal or debilitating conditions may soon be able to access psychedelics under a new bill.
End of content
End of content